3. Bibliografía

Durand RE. Tumor repopulation during radiotherapy: Quantitation in two xenografted human tumors. Int J Radiat Oncol Biol Phys 1997; 39(4):803-8.

Durand RE, Aquino-Parsons C. Predicting response to treatment in human cancers of the uterine cervix: sequential biopsies during external beam radiotherapy.Int J Radiat Oncol Biol Phys 2004; 58(2):555-60.

Fowler JF, Lindstrom MJ. Loss of local control with prolongation in radiotherapy. Int J. Radiat. Oncol. Biol. Phys 1992; 23 (2):457-67.

Fyles A, Keane TJ, Barton M, Simm J. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol 1992; 25(4):273-9.

Garzetti G, Ciavattini A, Lucarini G, Goteri G, de Nictolis M, Muzzioli M. MIB-1 immunostaining in stage I squamous cervical carcinoma: relationship with natural killer activity. Gynecol Oncol 1995; 58(1): 28-33.

Gasparini G, Bevilacqua P, Bonoldi E, Testolin A, Galassi A, Verderio P, Boracchi P, Guglielmi RB, Pezzella F. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.Clin Cancer Res 1995;1(11):1375-83.

Graflund M, Sorbe B, Bryne M, Karlsson M. The prognostic value of a histologic grading system, DNA profile, and MIB-1 expression in early stages of cervical squamous cell carcinomas. Int J Gynecol Cancer 2002; 12(2):149-57.

Ho DM, Hsu CY, Chiang H. MIB-1 labeling index as a prognostic indicator for survival in patients with FIGO Stage IB Squamous cell carcinoma of the cervix. Gynecologic oncology 2000; 76(1):97-102.

Homma A, Furuta Y, Oridate N, Nakano Y, Kohashi G, Yagi K, Nagahashi T, Yagi K, Nagahashi T, Fukuda S, Inoue K, Inuyama Y. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy. Clin Cancer Res 1999;5(4):801-6.

Kamer SA, Yalman D, Öxer E, Sayhan S, Hanhan M, Özsaran A, Haydaroglu A. Changes of ki-67 index in squamous cell carcinoma of the cerviz during the early course of radiotherapy and prediction of prognosis. Eur J Gynaecol Oncol 2003; 24(3-4):287-92.

Lanciano RM, Pajak TF, Martz K, Hanks GE. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study. Int J. Radiat. Oncol. Biol. Phys 1993; 25(3):391-7.

Lara P.C, Navarro D, Lloret M. Proliferación tumoral. Biocancer.com 2004; volumen 1.

Levine EL, Renehan A, Gossiel R, Davidson SE, Roberts SA, Chadwick C, et al. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. Radiother Oncol 1995; 37(1):1-9.

Radiother Oncol 1999; 50(1):93-101.

Tsang RW, Juvet S, Pintilie M, Hill RP, Wong CS, Milosevic M, Chapman W, Levin W, Manchul LA, Fykes AW. Pretreatment proliferation parameters do not add predictive power to clinical factors in cervical cancer treated with definitive radiation therapy. Clin Cancer Res 2003; 9(12):4387-95.

Tucker SL, Chan KS. The selection of patients for accelerated radiotherapy on the basis of tumor growth kinetics and radiosensitivity. Radiother. Oncol 1990; 18(3):197-211.

Van de putte G, Kristensen GB, Lie AK, Baekelandt M, Holm R. Cyclins and proliferation markers in early squamous cervical carcinoma. Gynecol Oncol 2004; 92(1):40-6.

Liu SS, Tsang BK, Cheung AN, Xue WC, Cheng DK, Ng TY, Wong LC, Ngan HY. Anti-apoptotic proteins, apoptotic and proliferative parameters and their prognostic significance in cervical carcinoma. Eur J Cancer 2001; 37(9):1104-10.

Lloret M, Pérez S, Santana C, Lera J, Rey A, Falcón O, Lara P.C. Proliferación (IM, Ki67), apoptosis (IA) y genes reguladores (P53, BAX y BCL-2) en carcinoma de cérvix: relación con factores pronósticos clásicos, control local y supervivencia. Carcinoma infiltrante de Cérvix: de los aspectos clínicos a la investigación aplicada. Editorial Bristol-Myers,S.A 2001; D.L:M-15738.Capítulo 3:53-69.

Lloret M, Apolinario R, Clavo B, Santana C, Falcón

0,Lara P.C .Proliferación tumoral en cáncer de cérvix. Angiogenesis y regulación génica. Hipoxia tumoral: relación con la proliferación y la apoptosis. Carcinoma infiltrante de Cérvix: de los aspectos clínicos a la investigación aplicada. Editorial Bristol-Myers,S.A 2001; D.L:M-15738.Capítulo 4:73-87.

Nakano T, Oka K, Ishikawa A, Morita S. Immunohistochemical prediction of radiation response and local control in radiation therapy for cervical cancer. Cancer Detect Prev 1998; 22(2):120-8.

Oka K, Nakano T, Hoshi T. Analysis of response to radiation therapy of patients with cervical adenocarcinoma compared with squamous cell carcinoma. MIB-1 and PC10 labeling indices. Cancer 1996; 77(11):2280-85.

Oka K, Suzuki Y, Nakano T. High growth fraction at 9 grays of radiotherapy is associated with a good prognosis for patients with cervical squamous cell carcinoma. Cancer (Phila.) 2000; 89(7):1526-31.

Padovan P, Salmaso R, Marchetti M, Padovan R. Prognostic value of bcl-2, p53 and ki-67 in invasive squamous carcinoma of the uterine cervix. Eur J Gynaecol Oncol 2000;21(3):267-72.

Pillai MR, Jayaprakash PG, Nair MK. Tumour-proliferative fraction and growth factor expression as markers of tumour response to radiotherapy in cancer of the uterine cervix J Cancer Res Clin Oncol 1998;124(8):456-61.

Suzuki M, Tsukagoshi S, Saga Y, Ohwada M, Sato

1. Assessment of proliferation index with MIB-1 as a prognostic factor in radiation therapy for cervical cancer. Gynecologic oncology 2000; 79(2):300-4.

Tsang RW, Fyles AW, Kirkbride P, Levin W, Manchul LA, Rawlings GA., Banerjee, D., Pintilie, M., Wilson, G.D. Proliferation measurements with flow cytometry Tpot in cencer of the uterine cervix:correlation between two laboratories and preliminary clinical

results. Int J. Radiat. Oncol. Biol. Phys 1995; 32(5):1319-29.

Tsang RW, Fyles AW, Li Y, Rajaraman MM, Chapman W, Pintilie M, Wong CS. Tumor proliferation and apoptosis in human uterine cervix carcinoma I: correlation s between variables.Radiother Oncol 1999;50(1):85-92.

Tsang RW, Wong CS, Fyles AW, Levin W, Manchul LA, Milosevic M, et al. Tumour proliferation and apoptosis human uterine cervix carcinoma II: correlation with clinical outcome.

Wilson GD, Dische S, Saunders MI. Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy. Radiother. Oncol 1995; 36(3):189-97.

Withers HR, Taylor JMG, Maciejewski, B. The hazard of accelerated tumour clonogen repopulation during radiotherapy. Acta Oncologica 1988; 27(2):131-46.

Wong WS, McGuire LJ. Tumor growth fraction in cervical carcinoma. Gynecol Oncol 1991; 40 (1):48-54.